Den prognostiske værdi af insulinlignende vækstfaktor I - IGF-I - og bindingsproteinet IGFBP-3 ved alkoholisk leversygdom

Ugeskrift for Laeger

Volumn 159, Issue 30, 1997, Pages 4636-4640

  Møller, Søren ^a   Becker, Povl Ulrik ^a   Juul, Anders ^a   Skakkebœk, Niels E ^a   Christensen, Erik ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIISOPROPYL 1,3-DITHIOL-2-YLIDENEMALONATE; MALONIC ACID DERIVATIVE; MALOTILATE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER DISEASES, ALCOHOLIC; MALE; MALONATES; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0031582529     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993; 55: 131-53.
2. Baxter RC. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993; 4: 91-6.
3. Møller S, Becker U. Insulin-like growth factor-I and growth hormone in chronic liver disease. Dig Dis 1992; 10: 239-48.
4. Kratzsch J, Blum WF, Schenker E, Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF) I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol Diabetes 1995; 103: 285-91.
5. Caufriez A, Reding P, Urbain D, Golstein J, Copinschi G. Insulin-loke growth factor-I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest 1991; 14: 317-21.
6. Møller S, Grønbæk M, Main K, Becker U, Skakkebæk NE. Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor-I (IGF-I) in patients with alcoholic cirrhosis. J Hepatol 1993; 17: 315-20.
7. Møller S, Juul A, Becker U, Flyvbjerg A, Skakkebæk NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995; 80: 1148-57.
8. Donaghy A, Ross R, Gimson A, Cwyfan Hughes S, Holly J, Williams R. Growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21: 680-8.
9. Christensen E, Schlichting P, Kragh-Andersen P, Fauerholdt L, Schou G, Pedersen VB et al, and The Copenhagen Study Group for Liver Diseases. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21: 163-74.
10. Keiding S, Badsberg JH, Becker U, Bentsen KD, Bonnevie 0, Caballeria et al. The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival. J Hepatol 1994; 20: 454-60.
11. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults; relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994; 78: 744-52.
12. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-8.
13. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebæk NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, -2, and -3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 1994; 41: 85-93.
14. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology 1987; 7: 1346-58.
15. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
16. Williams R. Current problems and new advances in liver transplantation. I: Rodés J, Arroyo V, eds. Therapy in liver diseases. Barcelona: Ediciones Doyma, 1992: 175-9.
17. Phillips ID, Arany E, Strain AJ, Han VKM, Hill DJ. Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat. J Endocrinol 1993; 137: 271-80.
18. Villafuerte BC, Koop BL, Pao C-I, Gu L, Birdsong GG, Phillips LS. Coculture of primary rat hepatocytes and non-parenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology 1994; 134: 2044-50.
19. Ross RJM, Chew SL, Li LD, Yateman M, Rodriguezarnao J, Gimson A et al. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver. J Endocrinol 1996; 149: 209-16.